Form D · Venture Capital Fund

MPM ONCOLOGY INNOVATIONS FUND LP

Cambridge, MA · CIK 0001719960

Offering snapshot reported Feb 26, 2020 · SEC filing

Reported sold: $98.9M
Investors reported: 36
Minimum accepted: $0
First sale: Jul 12, 2018

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$52,650,002 → $98,879,004
Reported investors31 → 36

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Feb 26, 2020	Amendment	$98,879,004	$46,229,002vs Jul 1, 2019	36	SEC filing
Jul 1, 2019	Amendment	$52,650,002	No comparison	31	SEC filing
Jun 29, 2018	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund, Other
Exemptions: 06b, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0 (estimated)
Finders' fees: $0
Form D file number: 021-315855

Limited Partnership Interests. The General Partner may waive the minimum capital commitment of $250,000 in its sole discretion.

INVESTORS WHO ARE CLIENTS OF UBS FINANCIAL SERVICES INC. ("UBS") MAY PAY TO UBS A FEE OF UP TO 2% OF THEIR COMMITMENT. ALSO, THE MANAGEMENT COMPANY PAYS TO UBS A PORTION OF THE MANAGEMENT FEE OTHERWISE PAID TO IT BY THE FUND IN RESPECT OF SUCH INVESTORS.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
None	None	UBS Financial Services Inc. · CRD 8174

Source: Form D, filed Feb 26, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

MPM ONCOLOGY INNOVATIONS FUND L.P.

Investment adviser: MPM ASSET MANAGEMENT LLC

Gross asset value: $131M
Beneficial owners: 36
ADV minimum commitment: $250K

Reported in Form ADV on Apr 28, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator STANDISH MANAGEMENT, LLC SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor KPMG LLP BOSTON, Massachusetts, United States

Custodian JEFFERIES LLC NEW YORK, New York, United States Related to adviser: No

Custodian SILICON VALLEY BANK NEWTON, Massachusetts, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

KPMG LLP
PCAOB 185

JEFFERIES LLC
SEC 8-15074

SILICON VALLEY BANK
LEI 549300A7DTSCJLJ33451

Filing source

Form ADV 2098941 · Apr 28, 2026 · Schedule D 7.B.(1), fund 805-5597744552

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Luke Evnin	Executive, Promoter
Ansbert Gadicke	Executive, Promoter
N/A Mpm Oncology Innovations Fund Gp Llc	Executive, Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

450 Kendall Street
Cambridge, MA, 02142